CSE

The More Life Company Corp.

MLCO.CN•Healthcare•Drug Manufacturers - Specialty & Generic
Current Price
$0.05
Today's Change
+0.00%
Market Cap
$22.85M
Volume
6.93K

Financials from The More Life Company Corp.'s company filings · Latest period: 2025-Q2 (ended )

Latest results: Q2 2025

See every quarter

Revenue

$26.0K

-7.1% vs a year earlier

Net loss

$616.0K

Operating cash flow

-$726.0K

Cash

$997.0K

💡 Quick Take

Mountain Valley MD Holdings Inc. is a biotech company focused on enhancing health solutions for humans, animals, and plants in Canada. While the company boasts a strong liquidity position with a current ratio of 15.04 and no debt, it faces significant concerns with extremely negative EBITDA and net margins, indicating operational challenges. The market cap of $22.85M and low share price of $0.05 suggest a lack of investor confidence, despite its innovative offerings. Overall, the company’s financial health shows promise in liquidity but raises red flags regarding profitability and operational efficiency.

Based on 21 data points⚠️Not financial advice

📊 Key Metrics

52 Week High$0.10
52 Week Low$0.01
Avg Volume148.04K
Beta-2.69
Shares Outstanding457.00M

🔥 Valuation

Market Cap$22.85M
Enterprise Value$21.43M
P/E Ratio-5.15
EV/EBITDAN/A
Dividend Yield0.00%

Loading financial metrics...

🚩 Red Flags

🔴

Cash Runway Critical

Company has $997K in cash but burned $810K last quarter. At this burn rate, only 1.2 quarters of runway remain without additional financing.

🟠

Revenue Declining

Revenue fell 87.7% year-over-year from $382K to $47K. The decline has persisted for multiple quarters.

🟠

Significant Losses

Company posted a loss of $-7.4M over the last year, representing 15759.6% of revenue.

🟠

Persistent Cash Burn

Operating cash flow has been negative for 3 consecutive quarters, burning $3.2M over the last year.

🌟 Opportunities

🚀

Gross margin expanded by 38.8 percentage points, indicating improved pricing power or cost efficiency.

🚀

Debt-free balance sheet with a solid cash position, providing significant financial flexibility.

🚀

Excellent liquidity with current ratio of 15.0x ensures operational stability.

✨

Low debt-to-revenue ratio of 0.0% indicates conservative financial management.

Want the Complete Picture?

Valuation, risk assessment, competitive positioning, and key insights — all in one report.

Free account:3 reports remaining

Recent Developments

Loading news...

Similar companies

Other Drug Manufacturers - Specialty & Generic companies of a similar size